A description and overview of teclistamab and its mechanism of action.
Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
Danai Dima, MD, further explores the patient characteristics in the R/R MM teclistamab real-world study.
Discussion of the real-world effectiveness of teclistamab in R/R MM and the impact on treatment guidelines and practice.
Presenting real-world data on the efficacy and safety of teclistamab for R/R MM.
Explanation of how these data apply to community oncologists.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
